Beijing Wantai Valuation
| 603392 Stock | 72.94 0.92 1.28% |
At this time, the firm appears to be overvalued. Beijing Wantai Biological shows a prevailing Real Value of USD62.45 per share. The current price of the firm is USD72.94. Our model approximates the value of Beijing Wantai Biological from analyzing the firm fundamentals such as Profit Margin of (0.12) %, current valuation of 87.71 B, and Return On Equity of -0.0226 as well as examining its technical indicators and probability of bankruptcy.
Price Book 7.4279 | Enterprise Value 87.7 B | Enterprise Value Ebitda 848.7828 | Price Sales 36.7241 | Enterprise Value Revenue 35.2234 |
Overvalued
Today
Please note that Beijing Wantai's price fluctuation is very steady at this time. Calculation of the real value of Beijing Wantai Biological is based on 3 months time horizon. Increasing Beijing Wantai's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Beijing Wantai is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Beijing Stock. However, Beijing Wantai's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 72.94 | Real 62.45 | Hype 72.94 | Naive 70.48 |
The real value of Beijing Stock, also known as its intrinsic value, is the underlying worth of Beijing Wantai Biological Company, which is reflected in its stock price. It is based on Beijing Wantai's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Beijing Wantai's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Beijing Wantai Biological helps investors to forecast how Beijing stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Beijing Wantai more accurately as focusing exclusively on Beijing Wantai's fundamentals will not take into account other important factors: Beijing Wantai Cash |
|
Beijing Wantai Total Value Analysis
Beijing Wantai Biological is presently forecasted to have takeover price of 87.71 B with market capitalization of 91.46 B, debt of 81.14 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Beijing Wantai fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
87.71 B | 91.46 B | 81.14 M |
Beijing Wantai Investor Information
About 82.0% of the company shares are owned by insiders or employees . The company recorded a loss per share of 0.23. Beijing Wantai Biological last dividend was issued on the 3rd of June 2024. The entity had 1.4:1 split on the 5th of June 2023. Beijing Wantai Biological is not in a good financial situation at this time. It has a very high odds of going through financial crisis in January.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Total Cash From Operating Activities | 1.2 B | 1.5 B |
|
| |||||
| Operating Income | 1.5 B | 1.6 B |
|
|
Beijing Wantai Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Beijing Wantai has an asset utilization ratio of 35.07 percent. This suggests that the Company is making USD0.35 for each dollar of assets. An increasing asset utilization means that Beijing Wantai Biological is more efficient with each dollar of assets it utilizes for everyday operations.Beijing Wantai Ownership Allocation
Beijing Wantai holds a total of 1.27 Billion outstanding shares. Beijing Wantai Biological shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 81.86 percent of Beijing Wantai Biological outstanding shares that are owned by insiders signifies that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Beijing Wantai Profitability Analysis
The company reported the revenue of 5.51 B. Net Income was 1.25 B with profit before overhead, payroll, taxes, and interest of 9.99 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Beijing Wantai's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Beijing Wantai and how it compares across the competition.
About Beijing Wantai Valuation
The stock valuation mechanism determines Beijing Wantai's current worth on a weekly basis. Our valuation model uses a comparative analysis of Beijing Wantai. We calculate exposure to Beijing Wantai's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Beijing Wantai's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 4.7 B | 3.4 B |
Beijing Wantai Quarterly Retained Earnings |
|
Complementary Tools for Beijing Stock analysis
When running Beijing Wantai's price analysis, check to measure Beijing Wantai's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Beijing Wantai is operating at the current time. Most of Beijing Wantai's value examination focuses on studying past and present price action to predict the probability of Beijing Wantai's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Beijing Wantai's price. Additionally, you may evaluate how the addition of Beijing Wantai to your portfolios can decrease your overall portfolio volatility.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |